Peptide stacks · Healing and repair

GLOW peptide blend: what’s in it and the evidence

Checked against our library and study pagesPublished by PepVault

GLOW is a blend of three compounds, BPC-157, TB-500 and GHK-Cu, that the peptide community runs for repair and recovery. The vial the library records holds 70 mg of powder in all: 50 mg of GHK-Cu and 10 mg each of BPC-157 and TB-500.

This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.

What’s in GLOW

The three parts of GLOW
PartAmountWhat it’s there forEvidence (library)
BPC-15710 mg in the vial; 250 mcg per dose reportedNew blood vessels, tendon & gut repairEmerging
TB-50010 mg in the vial; 250 mcg per dose reportedCell migration & wound repairEmerging
GHK-Cu50 mg in the vial; 1–2 mg per dose reportedCollagen & skin remodelingEmerging

What the 70 mg vial holds, part by part

  • GHK-Cu50 mg

  • BPC-15710 mg

  • TB-50010 mg

Each bar is one part’s share of the powder in the vial the library records for GLOW.

BPC-157

In GLOW, BPC-157 is listed for “New blood vessels, tendon & gut repair”. A peptide derived from a protective protein in the stomach.

TB-500

In GLOW, TB-500 is listed for “Cell migration & wound repair”. A fragment of thymosin beta-4, a protein the body uses for cell repair.

GHK-Cu

In GLOW, GHK-Cu is listed for “Collagen & skin remodeling”. A small copper-binding peptide found naturally in the blood and widely used in skincare.

A smiling man in a grey training top on a sofa with a foam roller beside him, his phone in his hands

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Has GLOW been studied as a combination?

1 study page of ours tested BPC-157, TB-500 and GHK-Cu together:

What the library says about the evidence for GLOW

The research behind each peptide is mostly cell and animal work, and the blend itself hasn't been formally studied. No study has tested the safety of these three peptides together, so each compound's own notes apply and add up. The one combination test, BPC-157 with TB-500 in rats, found no added benefit (Biçer 2026).

The studies of the parts, one by one: 14 study pages on BPC-157 (2 in people), 9 study pages on TB-500 (2 in people) and 11 study pages on GHK-Cu (2 in people).

What people commonly report on GLOW

Commonly reported: firmer skin and smoother recovery after procedures and small injuries. Firmer, smoother skin, and small injuries and procedures healing faster. Better skin texture and quicker bounce-back between training sessions.

These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.

Why these are combined

The library gives three reasons for combining the parts of GLOW:

  • GLOW is built on division of labor: BPC-157 rebuilds blood supply to damaged tissue, TB-500 moves repair cells in, and GHK-Cu boosts the collagen that rebuilds it. Each role comes from its own research, mostly in animals.
  • In GLOW, GHK-Cu also brings copper, which lysyl oxidase, the enzyme that cross-links collagen into strong fibers, needs to work, so new tissue laid down during repair matures stronger.
  • GLOW's skin side rests on GHK-Cu, its best-studied piece: in an 8-week trial with 40 women, a GHK-Cu serum cut wrinkle volume by about 24%, against 15% for a control serum. BPC-157 and TB-500 cover the deeper repair.

From the library’s notes on GLOW

A popular cosmetic and healing blend in the peptide community. Often run as a loading phase (daily 2 weeks) then maintenance (EOD).

“GHK-Cu + TB-500: skin plus recovery”, the library’s note on the pair (community report)

GHK-Cu works on collagen and skin, TB-500 on moving repair cells into damaged tissue, so the pair leans toward visible skin quality plus recovery.

“BPC-157 + TB-500 + GHK-Cu is the classic healing trio”, the library’s note on the three (community report)

Three peptides, three jobs: BPC-157 for blood supply and tendon and gut repair, TB-500 for moving repair cells in, and GHK-Cu for collagen and skin. Together they cover repair broadly without stacking the same pathway twice.

“GLOW aims skin-deep and structure-deep at once”, the library’s note on the three (community report)

GLOW is a split job: GHK-Cu works on collagen and skin at the surface, while BPC-157 and TB-500 work on the tissue repair underneath. GHK-Cu: small topical trials. In a randomized 8-week serum trial in 40 women, wrinkle volume fell 24% against 15% for a control serum (Badenhorst 2016); after laser resurfacing, blinded measures showed no difference (Miller 2006); no controlled injectable trial exists. BPC-157: rat studies plus three small uncontrolled human pilots (McGuire 2025). TB-500: no human exposure data (FDA, April 2026).

“Why GHK-Cu pairs with healing peptides”, the GHK-Cu entry’s note (community report)

GHK-Cu brings the skin and collagen side; BPC-157 and TB-500 bring tendon, gut and wound repair. Together they repair from the surface down, which is the logic behind GLOW. Each piece's evidence comes from its own studies: BPC-157 and TB-500 are almost entirely animal work, and GHK-Cu's human data are small topical skin trials. The only controlled test of any two combined, BPC-157 with TB-500 in 32 rats, found no added benefit in Achilles tendon repair (Biçer 2026); the full trio hasn't been studied.

The library’s notes on the smaller stacks inside GLOW, each on its own page:

How a GLOW vial is mixed and measured

The vial the library records for GLOW holds 70 mg of powder, mixed with 2 mL of bacteriostatic water. Every part dissolves into the same water, so each mL holds 25 mg of GHK-Cu, 5 mg of BPC-157 and 5 mg of TB-500.

GLOW’s vial with 2 mL of water, part by part
PartIn the vialSharePer mLIn 10 units (0.1 mL)
GHK-Cu50 mg71.4%25 mg2.5 mg
BPC-15710 mg14.3%5 mg500 mcg
TB-50010 mg14.3%5 mg500 mcg

One draw carries every part at the vial’s ratio. The 250 mcg of BPC-157 that GLOW’s entry lists is 5 units (0.05 mL) on a U-100 syringe, and that same draw holds 1.25 mg of GHK-Cu and 250 mcg of TB-500.

The ratio is fixed at 5 to 1 to 1 (GHK-Cu, BPC-157 and TB-500), so a draw that holds more of one part holds more of all of them; a pre-mixed vial can’t change one part on its own.

The arithmetic only divides what the vial holds by the water it is mixed with; it says nothing about what amount anyone should take.

Compared with running the parts apart

What the library says about GLOW against its parts on their own:

  • GHK-Cu is also applied to the skin on its own; creams, serums and gels are the only forms tested in controlled human trials.

Safety notes

The library’s combination safety note on GLOW

FDA (April 2026) says it has found no human exposure data for TB-500 and little or no safety data for BPC-157 and injectable GHK-Cu; it also flags a possible risk of immune reactions to compounded BPC-157, TB-500 and injectable GHK-Cu. Two threads are worth a clinician conversation: BPC-157 and TB-500 both promote new blood vessel growth in lab and animal studies, a theoretical concern with any existing or undiagnosed cancer, and GHK-Cu carries copper, relevant to copper-metabolism disorders such as Wilson's disease. Injection-site reactions are the most common effect in community reports.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Questions people ask

What is in GLOW?

GLOW is a blend of three compounds, BPC-157, TB-500 and GHK-Cu, that the peptide community runs for repair and recovery. The vial the library records holds 70 mg of powder in all: 50 mg of GHK-Cu and 10 mg each of BPC-157 and TB-500.

Has GLOW been studied together?

Yes: 1 study page of ours tested BPC-157, TB-500 and GHK-Cu together, starting with “BPC-157: non-significant tendon gains in rats; TB-500 did better”.

What do people report on GLOW?

Commonly reported: firmer skin and smoother recovery after procedures and small injuries. These are reports from people who run it.

How is a GLOW vial measured?

The vial the library records holds 70 mg with 2 mL of water, at a fixed ratio, so one draw carries every part; the reconstitution calculator works out the units for a vial.

What does each part of GLOW do?

The library lists BPC-157 for “New blood vessels, tendon & gut repair”, TB-500 for “Cell migration & wound repair” and GHK-Cu for “Collagen & skin remodeling”.

How does GLOW compare with taking the parts separately?

From the library: GHK-Cu is also applied to the skin on its own; creams, serums and gels are the only forms tested in controlled human trials.

More on these compounds

Track it in the app

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo